Keyword [Dual-target inhibitors] Result: 1 - 20 | Page: 1 of 2 |
1. | Design, Synthesis And Activity Evaluation Of Dual Target Inhibitors Of AD |
2. | Structure Based Design, Synthesis And Activity Studies Of Small Hybrid Molecules As HDAC And G9a Inhibitors |
3. | Design, Synthesis And Screening Of Protein Tyrosine Kinase Inhibitors |
4. | Design, Synthesis And Antitumor Activity Of HDACs-based Multi-target Inhibitors |
5. | Design,Dynthesis,Activity And Mechanism Studies Of Dual Inhibitors Of ?-glucosidase And PTP1B |
6. | The Impact And Mechanism Of Gold Nanoparticles Conjugated With Dual-target Inhibitors On The Radiosensitivity Of Triple-negative Breast Cancer Cell |
7. | Rational Design,Synthesis And Biological Evaluation Of HDAC-based Dual-target Inhibitors |
8. | Design,Synthesis And Biological Evaluation Of EGFR/HDAC-based Dual-Target Anticancer Drugs |
9. | Design,Synthesis And Evaluate Of Novel Dual HDAC And FGFR1 Inhibitors Bearing An Indazole Scaffold |
10. | The Anti-tumor Effect Of A Novel ALK/ROS1 Dual Target Inhibitors ZX-29 In Vitro And The Mechanism Of Drug Resistance Result From By ROS1 Mutation |
11. | Design,Synthesis And Biological Evaluation Of Novel HIV-1 Integrase/Ribonuclease H Dual Inhibitors And NNRTIs |
12. | Virtual Screening And Synthesis Of Novel INOS And COX-2 Dual-Target Inhibitors |
13. | Process Research Of Osimertinib And Design,Synthesis And Preliminary Activity Study Of EGFR And HDACs Dual-Target Inhibitors |
14. | Design,Synthesis And Anticancer Activity Study Of HDAC And VEGFR Dual-target Inhibitors |
15. | Design,synthesis And Biological Evaluation Of BTK/HDAC Dual Target Inhibitors In Mantle Cell Lymphoma |
16. | Design And Find Novel BTK/HDAC Dual Target Inhibitors To Treat Mantle Cell Lymphoma |
17. | Efficacy And Molecular Mechanism Of PIKfyve And Tubulin Dual-target Inhibitors HZX-02-059-01 On Double-Hit Lymphoma |
18. | Design And Synthesis Of PDE4/Tubulin And PDE4/AChE Dual Target Inhibitors |
19. | Design,Synthesis And Anti-Tumor Structure-Activity Relationships Of CDKs/HDACs Dual-Target Inhibitors |
20. | Virtual Screening Of Dual-target Inhibitors Of FTase And Raf-1 |
|